Clinical Trials Browser

Lung Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Carcinoma, Non-Small-Cell Lung

Adenocarcinoma of Lung

Neoplasms, Small Cell Lung Carcinoma

Mesothelioma, Malignant, Mesothelioma

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Fallopian Tube Neoplasms, Ovarian Neoplasms

Lung Neoplasms

Esophageal Neoplasms

Triple Negative Breast Neoplasms

Recurrence, Testicular Neoplasms, Seminoma

Breast Neoplasms

Triple Negative Breast Neoplasms

Non Small Cell Lung Cancer Metastatic

Non-small Cell Carcinoma

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Eye Neoplasms, Retinoblastoma, Retinal Neoplasms

Urinary Bladder Neoplasms

Breast Neoplasms

Esophageal Squamous Cell Carcinoma

Radiation Injuries, Disease Progression

Stage III and IV Ovarian Cancer

Hepatoblastoma

Neoplasms, Endometrial Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Diseases

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Triple Negative Breast Neoplasms

Carcinoma, Non-Small-Cell Lung, Neoplasms

Mesothelioma, Malignant, Mesothelioma

Nonseminomatous germ cell tumor, Choriocarcinoma, Neoplasms, Germ Cell and Embryonal, Teratoma, Germinoma, Seminoma, Endodermal Sinus Tumor

Carcinoma, Non-Small-Cell Lung

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck

Ovarian Neoplasms

Carcinoma, Squamous Cell

Endometrial Clear Cell Adenocarcinoma

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

Endometrial Neoplasms

Breast Neoplasms

Invasive Breast Cancer

Breast Neoplasms

Clinical Trials

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

NIRVANA-LUNG

CRYOMUNE

TRIPLEX

DREAM3R

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

ESO-Nanjing7

Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer

SWENOTECA-ABC

PANSY

SASCIA

ELDERLY

TOP

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer

Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma

NAUTICAL

TCTN

ESO-Nanjing12

Omitting CTV for Primary Tumor in LS-SCLC

Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

AtTEnd

Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC

NADIM-ADJUVANT

ARIAN

ProBio

CITRINE

EURTAC

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors

Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist（Diphenhydramine）in Advanced and Metastatic Non-Small Cell Lung Cancer

INTERLACE

Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline

Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)

ANITA

The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer

Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol

Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC

To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

ESOPEC

EC-01

TRAIN-2

APTneo

Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer